We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Survival Rates Double for Patients with Melanoma Brain Metastases Receiving Immunotherapy

News   Jul 12, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Survival Rates Double for Patients with Melanoma Brain Metastases Receiving Immunotherapy
 
 
 

RELATED ARTICLES

Non-circulating T Cells Vital for Protection against Salmonella

News

Noncirculating T cells are relatively unknown, but appear to be a vital component of immunity to Salmonella infection — and should be the focus of vaccine strategies.

READ MORE

3D Microfluidic Platform Enables Neuronal Chemotactic Assays

News

Shedding light on neural regeneration mechanism by recognizing subtle variation in the gradient profiles of guidance molecules.

READ MORE

Stealth-cap Technology for Light-emitting Nanoparticles

News

A team of scientists from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), in collaboration with researchers from Monash University Australia, has succeeded in significantly increasing the stability and biocompatibility of special light-transducing nanoparticles.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE